Keith Katkin's Net Worth
$16.2 Million
Who is Keith Katkin?
Keith Katkin has an estimated net worth of $16.2 Million. This is based on reported shares across multiple companies, which include RIGEL PHARMACEUTICALS INC, Carbylan Therapeutics, Inc., Syndax Pharmaceuticals Inc, Emergent BioSolutions Inc., Urovant Sciences Ltd., Novus Therapeutics, Inc., and AVANIR PHARMACEUTICALS.
SEC CIK
Keith Katkin's CIK is 0001314596
Past Insider Trading and Trends
2022 was Keith Katkin's most active year for acquiring shares with 11 total transactions. Keith Katkin's most active month to acquire stocks was the month of April. 2010 was Keith Katkin's most active year for disposing of shares, totalling 38 transactions. Keith Katkin's most active month to dispose stocks was the month of December. 2020 saw Keith Katkin paying a total of $694,800.00 for 644,587.15 shares, this is the most they've acquired in one year. In 2014 Keith Katkin cashed out on 1,370,751 shares for a total of $7,295,959.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $13.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 25K |
—
|
—
| 25K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Carbylan Therapeutics, Inc. (KALV) Snapshot price: $12.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $19.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.42% | 17K |
—
|
—
| 65K |
Feb 7
| |||
Form 4
| +50.00% | 16K |
—
|
—
| 48K |
Feb 2
| |||
Form 4
|
—
|
0
|
$17.05 | -$529,234.04 | 32K |
Scheduled
|
Oct 6
| ||
Form 4
|
—
|
0
|
$16.59 | -$69,533.73 | 32K |
Scheduled
|
Sep 30 - Oct 4
| ||
Form 4
| +100.00% | 16K |
—
|
—
| 32K |
Feb 2
| |||
Form 4
|
∞
| 16K |
—
|
—
| 16K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Emergent BioSolutions Inc. (EBS) Snapshot price: $7.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.07% | 17.43K |
—
|
—
| 59.87K |
May 23
| |||
Form 4
| +393.80% | 33.85K |
—
|
—
| 42.44K |
May 25
| |||
Form 4
|
∞
| 8.6K |
—
|
—
| 8.6K |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
PEO;CEO/Urovant Sciences, Inc.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$8.47 | -$1,659,600.00 | 199.68K |
Feb 19
| |||
Form 4
|
∞
| 199.68K |
—
|
—
| 199.68K |
Jan 7
| |||
Form 4
|
—
|
0
|
$8.32 | -$1,070,400.00 |
0
|
Scheduled
|
Dec 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||